I suspect EYE will have better revenue growth when they release their latest figures considering they had 65% growth even when 2 months were negatively affected by uncertainty about insurance reimbursement (which have now been resolved) and they've recently increased their sales force.
But yes agreed 75% growth is impressive. Looks like Vanguard have picked a winner
Ann: First $A9M sales month and $A10M revenue month, page-19
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
-0.030(1.45%) |
Mkt cap ! $1.409B | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.11 | $2.03 | $1.727M | 838.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 299194 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.04 | 1559 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |